CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Largest healthcare companies by operating income — page 2

Ranks 101–197 of 197 · Fiscal year 2025 · Data as of September 25, 2026

Operating income
#CompanyOperating incomeYoY15-year trend
101AnaptysbioANABUS$227M+243.0%
102Stevanato GroupSTVNIT$225M+28.8%
103Integer HoldingsITGRUS$221M+6.3%
104Envista HoldingsNVSTUS$216M+$1.3B
105Pediatrix MedicalMDUS$209M+$278M
106Harmony BiosciencesHRMYUS$208M+9.2%
107LivanovaLIVNGB$199M+54.5%
108Adma BiologicsADMAUS$191M+37.7%
109PenumbraPENUS$189M+1,939.5%
110Merit Medical SystemsMMSIUS$185M+18.6%
111Collegium PharmaceuticalCOLLUS$180M+5.7%
112InnovivaINVAUS$164M−1.9%
113Krystal BiotechKRYSUS$161M+145.3%
114HaemoneticsHAEUS$157M−29.3%
115CormedixCRMDUS$150M+$172M
116Sotera HealthSHCUS$148M−50.4%
117Trulieve CannabisTRLVUS$143M+46.8%
118Amphastar PharmaceuticalsAMPHUS$140M−31.7%
119Addus HomecareADUSUS$139M+35.0%
120National HealthcareNHCUS$128M+42.8%
121Rigel PharmaceuticalsRIGLUS$125M+418.6%
122TG TherapeuticsTGTXUS$123M+194.1%
123TeleflexTFXUS$118M+14.2%
124Bausch & LombBLCOCA$113M−30.2%
125Ani PharmaceuticalsANIPUS$111M+18,922.8%
126Phibro Animal HealthPAHCUS$110M+107.2%
127Transmedics GroupTMDXUS$109M+189.6%
128Hims & Hers HealthHIMSUS$106M+70.6%
129Aurinia PharmaceuticalsAUPHCA$105M+$110M
130Acadia PharmaceuticalsACADUS$105M−54.6%
131ConmedCNMDUS$103M−48.8%
132Bio-TechneTECHUS$102M−50.5%
133Emergent BiosolutionsEBSUS$100M+$209M
134Ironwood PharmaceuticalsIRWDUS$98.5M+5.8%
135Arrowhead PharmaceuticalsARWRUS$98.3M+$699M
136Ufp TechnologiesUFPTUS$92.3M+14.1%
137AdapthealthAHCOUS$90.9M−65.5%
138U S Physical TherapyUSPHUS$86.7M+37.6%
139InmodeINMDIL$85.4M−24.1%
140ProgynyPGNYUS$85.3M+26.4%
141AlvotechALVOLU$78.2M+12.3%
142Kiniksa Pharmaceuticals InternationalKNSAGB$77.2M+$123M
143Guardian Pharmacy ServicesGRDNUS$72.7M+$136M
144Lemaitre VascularLMATUS$67.9M+30.0%
145Healthcare ServicesHCSGUS$67.9M+28.2%
146Keros TherapeuticsKROSUS$67.6M+$278M
147SBC Medical GroupSBCUS$67.5M−4.0%
148Cadre HoldingsCDREUS$67.4M+0.9%
149Nu Skin EnterprisesNUSUS$65.8M+$217M
150Mimedx GroupMDXGUS$63.9M+8.5%
151RadnetRDNTUS$62.0M−40.7%
152National VisionEYEUS$58.8M+$69.2M
153VeracyteVCYTUS$57.8M+257.9%
154RepligenRGENUS$55.2M+$90.3M
155BioventusBVSUS$54.0M+$69.2M
156Pennant GroupPNTGUS$51.9M+36.1%
157Inspire Medical SystemsINSPUS$51.0M+41.2%
158Elite PharmaceuticalsELTPUS$49.1M+150.6%
159Caris Life SciencesCAIUS$45.1M+$302M
160Corcept TherapeuticsCORTUS$44.8M−67.3%
161Organogenesis HoldingsORGOUS$44.7M+$46.0M
162Icu MedicalICUIUS$42.8M−0.3%
163Ligand PharmaceuticalsLGNDUS$41.0M+$63.6M
164MannkindMNKDUS$38.8M−46.5%
165Usana Health SciencesUSNAUS$37.4M−43.6%
166Puma BiotechnologyPBYIUS$37.3M+20.5%
167Porch GroupPRCHUS$36.6M+$101M
168BioteBTMDUS$35.6M+12.5%
169Privia HealthPRVAUS$34.2M+101.6%
170ArtivionAORTUS$33.7M−13.2%
171HarrowHROWUS$30.5M+245.9%
172Telix PharmaceuticalsTLXAU$29.8M−46.0%
173Tactile Systems TechnologyTCMDUS$29.3M+32.0%
174KamadaKMDAIL$26.2M+30.8%
175Pharming GroupPHARNL$25.8M+$34.5M
176Curaleaf HoldingsCURLFUS$25.5M+2.9%
177Charles River Laboratories InternationalCRLUS$25.2M−88.9%
178Xeris BiopharmaXERSUS$24.9M+$58.5M
179Natures Sunshine ProductsNATRUS$24.7M+23.1%
180Lifestance HealthLFSTUS$24.1M+$55.8M
181Akebia TherapeuticsAKBAUS$23.5M+$74.0M
182Viemed HealthcareVMDUS$22.9M+28.2%
183NRC HealthNRCUS$22.6M−35.8%
184Pacira BiosciencesPCRXUS$19.2M+$92.6M
185VaxartVXRTUS$18.1M+$84.4M
186Niagen BioscienceNAGEUS$16.3M+110.7%
187BilliontooneBLLNUS$16.0M+$63.2M
188Alignment HealthcareALHCUS$14.8M+$116M
189TrupanionTRUPUS$13.8M+$23.4M
190Brookdale Senior LivingBKDUS$13.5M−71.0%
191LifevantageLFVNUS$12.2M+181.6%
192Infusystem HoldingsINFUUS$11.9M+73.0%
193VericelVCELUS$11.0M+144.4%
194AccurayARAYUS$7.8M+1,455.4%
195Xtant MedicalXTNTUS$7.3M+$19.4M
196Jushi HoldingsJUSHUS$4.9M−55.3%
197TalkspaceTALKUS$3.2M+$7.6M

All figures from SEC filings · FY2025 · 97

see sources

Download this data as a CSV →

Largest companies by operating income →

By sector

By country